MetaTOC stay on top of your field, easily

Establishing the clinical IDS pharmacist role in a phase 1 clinic

, , , , ,

Journal of Oncology Pharmacy Practice

Published online on

Abstract

Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundPhase 1 oncology clinical trials are complex and prioritize patient safety. Clinical pharmacists—experts in pharmacotherapy and patient-centered care—can enhance these trials by managing drug regimens and interactions. Despite demonstrated ...